Global Health: Research, Budgets, Challenges

2/11/2013 12:00 AM

In recent years, the medical attention of Western nations has expanded from disease prevention to include concern for the human environment and to priorities concerning the health and maintenance of the body as the population ages, particularity with respect to the negative impacts of poor diet. For instance, in the United States the leading causes of death are heart disease, cancer, respiratory disease, stroke, unintentional accidents, Alzheimer’s disease, and diabetes. The first two conditions on the list are responsible for 47% of total deaths. In the U.S., Alzheimer’s disease alone is projected to cause the death of 1/8 individuals over the age of 65 that have the disease, totaling approximately 5.4 million deaths. Age is also a factor with diabetes, where 26% of those over 65 were diagnosed with the disease in 2011. Similarly, over 77% of those diagnosed with cancer in the U.S. are identified as individuals 55 years or older, where men have been given a lifetime risk factor of 1 in 2, and women, 1 in 3.

With these prevailing health challenges on the horizon, how far away are we from developing effective cures? Secondly, due to scale and cost of treating such diseases, how can national governments best cope with these challenges? How can effective methods be created that are not only cost effective, but can be effectively exported to those affected in the developing world?

This panel discussion from the Blouin Creative Leadership Summit tackles these and other issues. Speakers: Drs. Yemi Adesokan, Barry Bloom, Todd Evans, Ihor Lemischka, Robert Orr, Shelia Ryan, Larry Young

Global Health - Research, Budgets, Challenges from Louise Blouin Foundation on